Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?

This publication has 19 references indexed in Scilit:

• Is MDMA (‘Ecstasy’) Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research
  Neuropsychobiology, 2000
• Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans
  Biological Psychiatry, 2000
• Serotonergic function after (±)3,4-methylene-dioxymethamphetarnine (‘Ecstasy’) in humans
  International Clinical Psychopharmacology, 1998
• Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics
  Biochemical Pharmacology, 1997
• Hormonal Responses to d- and d,l-Fenfluramine in Healthy Human Subjects
  Neuropsychopharmacology, 1996
• The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function
  Journal of Steroid Biochemistry, 1989
• Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects
  Pharmacology Biochemistry and Behavior, 1986
• Effects of acute cannabis use and short-term deprivation on plasma prolactin and dopamine-β-hydroxylase in long-term users
  Drug and Alcohol Dependence, 1982
• Tetrahydrocannabinols and serum prolactin levels in man
  Life Sciences, 1975
• Depression of Plasma Testosterone Levels after Chronic Intensive Marihuana Use
  New England Journal of Medicine, 1974